Publication of Data. Except for its own internal use in conjunction with the Agreement, Contractor may not publish or reproduce subject data in whole or in part, or in any manner or form, nor may Contractor authorize others to do so, without the written consent of the Federal Government, until such time as the Federal Government may have either released or approved the release of such data to the public; this restriction on publication, however, does not apply to any contract with an academic institution.
Publication of Data. Please refer to Section 9 (Registration and publication) in the Agreement for single-site publications.
Publication of Data. Any publication of clinical and scientific data relevant to the Product, generated under the terms of this Agreement, will be jointly planned and agreed upon in advance.
Publication of Data. Art. 32. The beneficiary agrees that the documents and information referred to in art. 24 regarding transparency to be published by the contracting authority, except for the personal data mentioned in letter a).
Publication of Data. Except for its own internal use in conjunction with the Agreement, Contractor may not publish or reproduce subject data in whole or in part, or in any manner or form, nor may Contractor authorize others to do so, without the written consent of the Federal Government, until such time as the Federal Government may have either released or approved the release of such data to the public; this restriction on publication, however, does not apply to any contract with an academic institution. Federal License. In accordance with 49 CFR §§ 18.34 and 19.36, the Federal Government reserves a royalty-free, non-exclusive and irrevocable license to reproduce, publish or otherwise use, and to authorize others to use, “for Federal Government purposes,” any subject data or copyright described below. As used in the previous sentence, “for Federal Government purposes” means use only for the direct purposes of the Federal Government. Without the copyright owner’s consent, the Federal Government may not extend its Federal license to any other party: Any subject data developed under this Agreement, whether or not a copyright has been obtained; and Any rights of copyright purchased by City or Contractor using Federal assistance in whole or in part provided by FTA. FTA Intention. When FTA awards Federal assistance for a experimental, research or developmental work, it is FTA's general intention to increase transportation knowledge available to the public, rather than to restrict the benefits resulting from the work to participants in the work. Therefore, unless FTA determines otherwise, the Contractor performing experimental, research, or developmental work required by the underlying Agreement agrees to permit FTA to make available to the public, either FTA's license in the copyright to any subject data developed in the course of the Agreement, or a copy of the subject data first produced under the Agreement for which a copyright has not been obtained. If the experimental, research, or developmental work which is the subject of this Agreement is not completed for any reason whatsoever, all data developed under this Agreement shall become subject data as defined in Subsection a. above and shall be delivered as the Federal Government may direct. This subsection does not apply to adaptations of automatic data processing equipment or programs for the City’s use the costs of which are financed with Federal transportation funds for capital projects. Hold Harmless. Unless prohibited by s...
Publication of Data. Roivant shall have the exclusive right to control the content, submission or retraction of any publications of data generated by Roivant with respect to any Selected Compound from and after the Closing Date. GSK shall retain the exclusive right to control the content, submission or retraction of any publications of data generated by GSK or its Affiliates with respect to any Selected Compound, including the publication of clinical trials generating such data on any Clinical Studies Register and for the avoidance of doubt, full study protocols and study conclusions. GSK shall share with Roivant proposed publications and related data for review and consider input from Roivant. While GSK reserves it rights to make the publications of data provided for above in this Section 10.3, GSK represents and warrants to Roivant as of the Closing Date that GSK does not contemplate doing so.
Publication of Data. Organization assumes all risks associated with enabling access to the Infinity Customer Engagement Portal to third parties and to the use of web enabled access to the Infinity CEP Software, whether such access is made available from within Organization’s firewall or via the Internet. Organization agrees to defend, indemnify and hold harmless Xxxxxx, its licensors, service providers, affiliates and each of their respective officers, directors, employees, and agents (the “Indemnities”) from and against all losses, costs, damages, liabilities, and expenses (including reasonable attorney’s fees) incurred by the Indemnities in any claim, action, suit or proceeding arising out of or in connection with the use of the Infinity Customer Engagement Portal, web based features or portions of the Infinity CEP Software, and/or any website operated by or on behalf of Organization that displays any part of the Infinity CEP Software and the publication, display and use of the information and data described and/or contained on the Infinity Customer Engagement Portal, web based features or portions of the Infinity CEP Software, or such website, including but not limited to any claim with respect to any improper or incorrect use of the information or any defamatory, offensive, or other illegal conduct of users or third parties.
Publication of Data. The Researcher agrees to comply with the following publication conditions:
Publication of Data. 5.1 Submission of data to the WHO Central Database does not affect the right of contributing sites to share or publish those data, which <INSERT ACRONYM OF TRANSFERRING PARTY> may do entirely at their own discretion and without consent from or reference to the WHO Central Database.
Publication of Data. 5.1 Submission of data to the WHO Global aDSM Database does not affect the right of contributing sites to share or publish those data, which <INSERT ACRONYM OF TRANSFERRING PARTY> may do entirely at their own discretion and without consent from or reference to the WHO Global aDSM Database.
